This invention relates to determining the dynamic modulus of materials and more particularly to a high-frequency dynamic indentation system for use with a commercial/custom made atomic force microscope (AFM) to extend analysis to higher frequencies.
Atomic force microscopes often include a piezoelectric actuator for dynamic indentation experiments on materials with time (frequency)-dependent mechanical properties such as cartilage to determine its dynamic modulus. For the case of cartilage, the frequency-dependent properties of the tissue can be used to detect GAG (Glycosamicoglycan)-depletion, which represents early stage arthritis.
The piezoelectric actuator in an AFM is not capable of high-frequency operation so that the complex dynamic modulus of cartilage, for example, cannot be sufficiently characterized. This information is needed in order to draw secondary conclusions about the sample under investigation, for example, to determine whether the cartilage is normal or GAG-depleted. The latter in this case would be an indication of the onset of arthritis.
It is therefore an object of the present invention to provide a secondary sample oscillation system to be used in conjunction with a commercial AFM that operates in a sufficiently high frequency range to enable proper characterization of the mechanical properties of the sample under investigation, for example, to distinguish normal cartilage from GAG-depleted cartilage. Of course, the system disclosed herein can be used with materials other than cartilage.
In one aspect, the rheology system of the invention includes a first piezoelectric actuator assembly for providing microscale displacement of a sample. A second piezoelectric actuator assembly is provided for oscillating the sample at a nano/micro scale displacement in a selected frequency range. It is preferred that the first piezoelectric actuator be part of an atomic force microscope (AFM). In a preferred embodiment, the microscale displacement provided by the first piezoelectric actuator is a ramp and hold displacement. The first piezoelectric actuator provides displacement in the range of approximately 2-4 μm.
In another preferred embodiment, the second piezoelectric actuator assembly includes a beam for supporting the sample and a substrate to which the beam is affixed in a spaced-apart relation. A piezoelectric actuator is positioned between the substrate and the beam to cause the beam to oscillate at a selected frequency and displacement upon piezoelectric actuator activation. It is preferred that the second piezoelectric actuator be pre-loaded against the beam in order to make the amplitude of the secondary piezo oscillation independent of the load, i.e., the sample weight. A suitable selected frequency is in the range of 1 I-Hz to 200 kHz. A suitable displacement effected by the second piezoelectric actuator is in the range of 1 to 50 nm. A suitable material for beam construction is carbon fiber or any other material with a high ratio of stiffness to density. It is also preferred that a mica layer be disposed between the beam and the sample to electrically isolate the secondary piezo.
a is a partially exploded view of an atomic force microscope along with the secondary piezoelectric actuator disclosed herein.
b is a graph of force and displacement against time showing the waveform generated by the primary piezoelectric actuator and the secondary piezoelectric actuator assembly.
c includes graphs of a typically applied displacement and measured force curves versus time featuring a phase lag between the force and displacement.
a shows the ratio of the piezo displacement to the applied voltage for both a commercial AFM (Bruker PicoForce) and the secondary piezoelectric actuator disclosed here.
b shows the phase lag between the piezo displacement and the applied voltage for both a commercial AFM (Bruker PicoForce) and the secondary piezoelectric actuator disclosed here.
a is a graph of dynamic modulus magnitude versus frequency for normal and GAG-depleted cartilage.
b is a graph of phase against frequency for normal and GAG-depleted cartilage.
In order to measure the dynamic modulus of cartilage at high frequencies (200 Hz<f<200 kHz) we developed the novel setup shown in
The AFM head 10 may be a commercial atomic force microscope such as the MFP-3D unit available from Asylum Research of Santa Barbara, Calif. The second piezoelectric actuator 22 is small, on the order of 2×2×2 mm in order to maximize its resonance frequency. It is preferred that the beam 16 material be carbon fiber in order to remove the resonances caused by the beam as the carbon fiber beam will have low weight and high stiffness. It is also preferred that the sample 14 be placed on a mica surface (not shown) which is securely glued to the carbon fiber beam 16. The mica surface would serve as an electrical insulator between the beam and the secondary piezo. The secondary piezoelectric actuator 22 is activated by an oscillatory frequency sweep signal (DC=5 volts, Amp=0.2 volts)/random binary sequence or other signals of interest for system identification which is generated in a function generator and as implemented in the experimental setup presented herein and can be based on LabView from the National Instrument Company of Austin, Tex. The generated frequency sweep signal/Random Binary Sequence was amplified by a custom-made amplifier in order to supply the required power at high frequencies.
As shown in
As shown in
Utilizing the high-frequency system disclosed herein, we measured the phase and magnitude of the complex dynamic moduli of normal and GAG-depleted cartilage at the nanoscale deformation as shown in
The contents of the above cited reference is incorporated herein by reference in its entirety.
It is recognized that modifications and variations of the invention disclosed herein will be apparent to those of skill in the art and it is intended that all such modifications and variations be included within the scope of the appended claims.
This invention was made with government support under Grant Nos. DMR0819762 and CMMI0758651 awarded by the National Science Foundation and under Grant No. R01 AR033236 awarded by the National Institutes of Health. The government has certain rights in this invention.
Number | Name | Date | Kind |
---|---|---|---|
5371365 | Watanabe et al. | Dec 1994 | A |
5426302 | Marchman et al. | Jun 1995 | A |
6215121 | Fujihira et al. | Apr 2001 | B1 |
6614227 | Ookubo | Sep 2003 | B2 |
20060027739 | Warren et al. | Feb 2006 | A1 |
20060283240 | Struckmeier et al. | Dec 2006 | A1 |
20110041223 | Jesse et al. | Feb 2011 | A1 |
20110167524 | Hu et al. | Jul 2011 | A1 |
20110167525 | Humphris | Jul 2011 | A1 |
Entry |
---|
C, Nia, HT, et al, Biophysical Journal 2011, 101, (9), 2304-2313. |